Published in Arch Ophthalmol on November 01, 1985
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest (1989) 2.16
Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol (1996) 1.56
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol (1995) 1.43
Results of scleral buckling operations in primary rhegmatogenous retinal detachment. Doc Ophthalmol (2000) 0.91
Effect of prophylactic 360° laser treatment for prevention of retinal detachment after phacovitrectomy: (Prophylactic 360° laser treatment for prevention of retinal detachment). BMC Ophthalmol (2013) 0.87
Neutrophils compromise retinal pigment epithelial barrier integrity. J Biomed Biotechnol (2010) 0.82
Retinal Pigment Epithelium and Müller Progenitor Cell Interaction Increase Müller Progenitor Cell Expression of PDGFRα and Ability to Induce Proliferative Vitreoretinopathy in a Rabbit Model. Stem Cells Int (2012) 0.81
[Comparison of the anatomical and functional outcome after laser or cryotherapy for retinopathy of prematurity (ROP)]. Ophthalmologe (2005) 0.81
Effect of peripheral retinal ablation with cryotherapy versus diode laser photocoagulation on axial length in the growing rabbit eye. Br J Ophthalmol (2006) 0.80
[Management of a ruptured globe]. Ophthalmologe (2008) 0.80
Transscleral diode photocoagulation of large retinal and choroidal vascular lesions. PLoS One (2012) 0.80
Surgical treatment of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.80
Vitreous fluorophotometry: a review. J R Soc Med (1988) 0.79
Evaluation of the blood-aqueous barrier by laser flare cell photometry following retinal cryocoagulation. Graefes Arch Clin Exp Ophthalmol (2003) 0.77
Buckle, no cryo: scleral buckle with no cryotherapy for retinal detachment secondary to commotio retinae. Br J Ophthalmol (2006) 0.75
Multicenter trial of transscleral diode laser retinopexy in retinal detachment surgery. Trans Am Ophthalmol Soc (1997) 0.75
Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits. J Ocul Pharmacol Ther (2011) 0.75
Pars plana vitrectomy with 360° versus localized laser retinopexy in the management of retinal detachment with undetected breaks intraoperatively: a retrospective, comparative, interventional study. Lasers Med Sci (2017) 0.75
Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol (1991) 3.09
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci (1999) 2.23
Subretinal fluid stimulation of retinal pigment epithelial cell migration and proliferation is dependent on certain features of the detachment or its treatment. Arch Ophthalmol (1989) 1.98
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol (2001) 1.94
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol (1997) 1.90
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther (2006) 1.86
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. Br J Ophthalmol (2009) 1.82
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. Clin Cancer Res (2001) 1.79
Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci (1998) 1.68
Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res (1997) 1.58
Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia. Br J Ophthalmol (2005) 1.49
Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol (1989) 1.49
Neurotrophic factors cause activation of intracellular signaling pathways in Müller cells and other cells of the inner retina, but not photoreceptors. Invest Ophthalmol Vis Sci (2000) 1.48
Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. Am J Hum Genet (1993) 1.45
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
Eye pain after vitreoretinal surgery: a prospective study of 185 patients. Retina (2001) 1.44
Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model. J Infect Dis (1995) 1.43
Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol (1989) 1.38
Ciliary body adenoma in a 10-year-old girl who had a rhabdomyosarcoma. Arch Ophthalmol (1992) 1.37
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol (1999) 1.34
Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol (1999) 1.31
Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol (1985) 1.30
Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res (1997) 1.29
Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol (2000) 1.28
The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci (1986) 1.28
Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci (1990) 1.26
Vitrectomy techniques in the management of selected penetrating ocular injuries. Ophthalmology (1978) 1.21
Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol (1998) 1.20
Surgical complications of pars plana vitreous surgery. Ophthalmology (1978) 1.19
Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem (1999) 1.19
Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am J Pathol (2001) 1.18
Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin. Arch Ophthalmol (1986) 1.17
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis (1993) 1.17
Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest (1996) 1.16
Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther (2004) 1.15
Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab (1981) 1.14
Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina. J Cell Physiol (1999) 1.14
Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol (1995) 1.13
Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1996) 1.13
Nonviral ocular gene transfer. Gene Ther (2005) 1.13
Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol (1985) 1.13
Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1990) 1.12
Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in mice. Am J Pathol (2001) 1.11
Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol (1984) 1.10
Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium. Invest Ophthalmol Vis Sci (2000) 1.09
Expression and permeation properties of the K(+) channel Kir7.1 in the retinal pigment epithelium. J Physiol (2001) 1.09
X-chromosone-linked juvenile retinoschisis with hemorrhagic retinal cyst. Am J Ophthalmol (1977) 1.08
Retinal thinning and regression of neovascularization. Arch Ophthalmol (1988) 1.07
Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology (1994) 1.07
Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol (2000) 1.07
Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol (1985) 1.06
11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. Mol Vis (1999) 1.05
Neurotrophic signaling in normal and degenerating rodent retinas. Exp Eye Res (2001) 1.04
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol (1997) 1.04
Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol (1995) 1.03
Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium. Hum Mol Genet (1999) 1.02
Gentamicin toxicity in the primate retina. Arch Ophthalmol (1989) 1.01
Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab (1980) 1.01
Macular oedema: the role of soluble mediators. Br J Ophthalmol (2000) 0.98
Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. Arch Ophthalmol (1986) 0.98
An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest Ophthalmol Vis Sci (1992) 0.96
TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopathol (2001) 0.96
Mammalian orthologs of C. elegans unc-119 highly expressed in photoreceptors. Invest Ophthalmol Vis Sci (1998) 0.95
Mammalian homolog of Drosophila retinal degeneration B rescues the mutant fly phenotype. J Neurosci (1997) 0.95
Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res (1995) 0.95
Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci (1990) 0.94
Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Diabetes (1988) 0.94
Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology (1987) 0.94
Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca mulatta. Science (1972) 0.94
Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery. Ophthalmology (2000) 0.93
Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol (1985) 0.92
Deletion (13)(q14.1q14.3) in two generations: variability of ocular manifestations and definition of the phenotype. Am J Med Genet (1987) 0.92
Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1991) 0.92
Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. Lab Invest (1990) 0.91
Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology (1993) 0.91
Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization. J Neuroimmunol (1998) 0.91
Management of endophthalmitis in a silicone oil-filled eye. Retina (1997) 0.90
Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment. Arch Ophthalmol (1986) 0.90
Successful treatment of gram-negative endophthalmitis with intravitreous ceftazidime. Arch Ophthalmol (1992) 0.90
Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther (2003) 0.90
Sustained expression after nonviral ocular gene transfer using mammalian promoters. Gene Ther (2006) 0.90
Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema. Histochem J (1994) 0.89
Human retinal pigment epithelial cells possess muscarinic receptors coupled to calcium mobilization. Brain Res (1988) 0.88
Class III beta-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes. Exp Eye Res (1995) 0.87
Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. Exp Eye Res (1993) 0.87
Hemangiomalike masses of the retina. Arch Ophthalmol (1988) 0.87
Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. J Histochem Cytochem (1990) 0.86
Retinal vascular occlusion without retrobulbar or optic nerve sheath hemorrhage after retrobulbar injection of lidocaine. Ophthalmic Surg (1988) 0.86
Pseudomonas aeruginosa allergy and humoral antibody-mediated hypersensitivity pneumonia. Am Rev Respir Dis (1973) 0.86